Ana Catarina Silva – författare

This book presents an overview of the convergence of traditional letterpress with contemporary digital design and fabrication practices.

Reflecting on the role of letterpress within the emergent hybrid post-digital design process, contributors present historical and contemporary analysis, grounded in case studies and current practice. The main themes covered include the research on letterpress as a technology and medium; a reflection on the contribution of letterpress to arts and design education; and current artistic and communication design practice merging past, present and future digital fabrication processes.

This will be of interest to scholars working in graphic design, communication design, book design, typography, typeface design, design history, printing, and production technologies.

This book presents an overview of the convergence of traditional letterpress with contemporary digital design and fabrication practices.

Reflecting on the role of letterpress within the emergent hybrid post-digital design process, contributors present historical and contemporary analysis, grounded in case studies and current practice. The main themes covered include the research on letterpress as a technology and medium; a reflection on the contribution of letterpress to arts and design education; and current artistic and communication design practice merging past, present and future digital fabrication processes.

This will be of interest to scholars working in graphic design, communication design, book design, typography, typeface design, design history, printing, and production technologies.

This book offers an authoritative review of biopharmaceuticals and their clinical relevance. Biopharmaceuticals have been showing high therapeutic potential by means of biological and biosimilar medicines, particularly for the treatment of cancer, chronic diseases (e.g. diabetes, Crohn''s disease, psoriasis and rheumatoid arthritis), neurodegenerative disorders (e.g. multiple sclerosis), and they have also been contributing to the progress of innovative therapies such as assisted reproductive medicine. Since the eighties, several biopharmaceuticals have been approved and, due to patents expiration, many biosimilars are also marketed.

In this book, readers will find the most relevant updated information about the main clinical applications of pharmaceutical biotechnology. The authors provide expert analysis about the industrial challenges of recombinant proteins and the different classes of biopharmaceuticals, including monoclonal antibodies, vaccines, growth factors and stem cells. Topics such as bioprinting technologies in tissue engineering, gene therapy and personalized medicine are also covered in this book. Professionals, students and researchers interested in this field will find this work an important account.

This book provides a compact and straightforward overview of the main concepts and applications of Pharmaceutical Biotechnology. The author collates lecture notes on Pharmaceutical Biotechnology to introduce the topic to graduate students in the fields of Pharmaceutical Sciences, Biochemistry, Biotechnology and Industrial Biotechnology, Microbiology, and Medicinal Chemistry.

The book starts with an overview of the biotechnological processes needed to develop biological and biosimilar medicines. Next, the author addresses the development and use of advanced therapy medicinal products (ATMPs), including topics such as cell and gene therapies, regenerative medicine and the regulatory issues of biological medicines and ATMPs. Finally, the author explores the limitations of administering biopharmaceuticals, discussing protein and nucleic acid stability issues, potential routes of administration and strategies for improving the bioavailability of biologics and ATMPs.

This book captures the latest developments in the field and offers a practical perspective on the topic, serving as a valuable introduction resource not only for graduate students but also for researchers.

The basis of the English translation of this book, originally in Portuguese, was facilitated by artificial intelligence. The content was later revised by the author for accuracy.